FTC sues main pharmacy benefit managers in excess of insulin rates The agency brought motion from Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the list cost of existence-preserving insulin prescription drugs. Given that some digital health startups funded during the height on https://lanevmdtj.popup-blog.com/30054332/5-simple-techniques-for-healthcare-news